Page last updated: 2024-09-04

resiquimod and gs-9620

resiquimod has been researched along with gs-9620 in 2 studies

Compound Research Comparison

Studies
(resiquimod)
Trials
(resiquimod)
Recent Studies (post-2010)
(resiquimod)
Studies
(gs-9620)
Trials
(gs-9620)
Recent Studies (post-2010) (gs-9620)
4651431846946

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Enosi Tuipulotu, D; Lun, JH; Mackenzie, JM; Netzler, NE; White, PA1

Other Studies

2 other study(ies) available for resiquimod and gs-9620

ArticleYear
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
TLR7 Agonists Display Potent Antiviral Effects against Norovirus Infection via Innate Stimulation.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:5

    Topics: Aminoquinolines; Animals; Antiviral Agents; Caliciviridae Infections; Cell Line; Guanosine; Humans; Imidazoles; Imiquimod; Mice; Pteridines; RAW 264.7 Cells; Toll-Like Receptor 7; Virus Replication

2018